Why does Ultragenyx’s first gene therapy approval matter for investors?

Ultragenyx’s FDA clearance for Genglycos in GSDIa marks its first gene therapy approval, shifting the company from pipeline story to approved genetic medicines player. The decision also brings a sellable voucher and potentially improves sentiment and credibility ahead of Ultragenyx’s next closely watched study readout.